Questions and Answers on RTS,S/ASO1 Malaria Vaccine
This web page provides answers to frequently asked questions about the RTS,S/AS01 (RTS,S) malaria vaccine, the world’s most advanced malaria vaccine candidate. RTS,S was developed through a partnership between GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative, with support from the Bill & Melinda Gates Foundation and a network of African research centers.
Author: World Health Organization
» Visit web page (English)
(Located at www.who.int)
Resource types: Website